DOI QR코드

DOI QR Code

Donor Selection, Management, and Procurement for Lung Transplantation

  • Yu, Woo Sik (Department of Thoracic and Cardiovascular Surgery, Ajou University School of Medicine) ;
  • Son, JeongA (Department of Thoracic and Cardiovascular Surgery, Ajou University School of Medicine)
  • Received : 2022.07.18
  • Accepted : 2022.07.18
  • Published : 2022.08.05

Abstract

Lung transplantation is a life-saving procedure in patients with end-stage lung disease. However, it inherently depends on the availability of donor organs. The selection of suitable lungs for transplantation, management of donors to minimize further injury and improve organ function, and safe procurement remain critical for successful transplantation. In this review, we provide an update on the current understanding of donor selection, management, and lung procurement.

Keywords

Acknowledgement

The authors are grateful to Woohyun Cho from Ajou University School of Medicine, Medical Information & Media Center, for his valuable contribution to creating the figures in this article.

References

  1. The National Institute of Organ, Tissue and Blood Management. Annual report for 2019 [Internet]. Seoul: The National Institute of Organ, Tissue and Blood Management; 2020 [cited 2022 Jun 20]. Available from: https://www.konos.go.kr/board/boardListPage.do?page=sub4_2_1&boardId=30.
  2. Sundaresan S, Trachiotis GD, Aoe M, Patterson GA, Cooper JD. Donor lung procurement: assessment and operative technique. Ann Thorac Surg 1993;56:1409-13. https://doi.org/10.1016/0003-4975(93)90699-I
  3. Bhorade SM, Vigneswaran W, McCabe MA, Garrity ER. Liberalization of donor criteria may expand the donor pool without adverse consequence in lung transplantation. J Heart Lung Transplant 2000;19:1199-204. https://doi.org/10.1016/S1053-2498(00)00215-1
  4. Pierre AF, Sekine Y, Hutcheon MA, Waddell TK, Keshavjee SH. Marginal donor lungs: a reassessment. J Thorac Cardiovasc Surg 2002;123:421-8. https://doi.org/10.1067/mtc.2002.120345
  5. Reyes KG, Mason DP, Thuita L, et al. Guidelines for donor lung selection: time for revision? Ann Thorac Surg 2010;89:1756-65. https://doi.org/10.1016/j.athoracsur.2010.02.056
  6. Barnard JB, Davies O, Curry P, et al. Size matching in lung transplantation: an evidence-based review. J Heart Lung Transplant 2013;32:849-60. https://doi.org/10.1016/j.healun.2013.07.002
  7. Ouwens JP, van der Mark TW, van der Bij W, Geertsma A, de Boer WJ, Koeter GH. Size matching in lung transplantation using predicted total lung capacity. Eur Respir J 2002;20:1419-22. https://doi.org/10.1183/09031936.02.00294402
  8. Orens JB, Boehler A, de Perrot M, et al. A review of lung transplant donor acceptability criteria. J Heart Lung Transplant 2003;22:1183-200. https://doi.org/10.1016/S1053-2498(03)00096-2
  9. Yu WS, Park CH, Paik HC, et al. Changes in thoracic cavity volume after bilateral lung transplantation. Front Med (Lausanne) 2022;9:881119.
  10. Aigner C, Mazhar S, Jaksch P, et al. Lobar transplantation, split lung transplantation and peripheral segmental resection: reliable procedures for downsizing donor lungs. Eur J Cardiothorac Surg 2004;25:179-83. https://doi.org/10.1016/j.ejcts.2003.11.009
  11. Shigemura N, Bermudez C, Hattler BG, et al. Impact of graft volume reduction for oversized grafts after lung transplantation on outcome in recipients with end-stage restrictive pulmonary diseases. J Heart Lung Transplant 2009;28:130-4. https://doi.org/10.1016/j.healun.2008.11.003
  12. Chambers DC, Yusen RD, Cherikh WS, et al. The registry of the International Society for Heart and Lung Transplantation: thirty-fourth adult lung and heart-lung transplantation report-2017; focus theme: allograft ischemic time. J Heart Lung Transplant 2017;36:1047-59. https://doi.org/10.1016/j.healun.2017.07.016
  13. Busl KM, Bleck TP. Neurogenic pulmonary edema. Crit Care Med 2015;43:1710-5. https://doi.org/10.1097/CCM.0000000000001101
  14. Yeo HJ, Yoon SH, Lee SE, et al. Current status and future of lung donation in Korea. J Korean Med Sci 2017;32:1953-8. https://doi.org/10.3346/jkms.2017.32.12.1953
  15. Mascia L, Pasero D, Slutsky AS, et al. Effect of a lung protective strategy for organ donors on eligibility and availability of lungs for transplantation: a randomized controlled trial. JAMA 2010;304:2620-7. https://doi.org/10.1001/jama.2010.1796
  16. Angel LF, Levine DJ, Restrepo MI, et al. Impact of a lung transplantation donor-management protocol on lung donation and recipient outcomes. Am J Respir Crit Care Med 2006;174:710-6. https://doi.org/10.1164/rccm.200603-432OC
  17. Minambres E, Coll E, Duerto J, et al. Effect of an intensive lung donor-management protocol on lung transplantation outcomes. J Heart Lung Transplant 2014;33:178-84. https://doi.org/10.1016/j.healun.2013.10.034
  18. Copeland H, Hayanga JW, Neyrinck A, et al. Donor heart and lung procurement: a consensus statement. J Heart Lung Transplant 2020;39:501-17. https://doi.org/10.1016/j.healun.2020.03.020
  19. Follette DM, Rudich SM, Babcock WD. Improved oxygenation and increased lung donor recovery with high-dose steroid administration after brain death. J Heart Lung Transplant 1998;17:423-9.
  20. Hwang HP, Kim JM, Shin S, et al. Organ procurement in a deceased donor. Korean J Transplant 2020;34:134-50. https://doi.org/10.4285/kjt.2020.34.3.134
  21. Nguyen DC, Loor G, Carrott P, Shafii A. Review of donor and recipient surgical procedures in lung transplantation. J Thorac Dis 2019;11(Suppl 14):S1810-6. https://doi.org/10.21037/jtd.2019.06.31